• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗中部法尔斯省临床分离株中多个基因的表达分析可能与抗锑性有关。

Expression Analysis of Multiple Genes May Involve in Antimony Resistance among Clinical Isolates from Fars Province, Central Iran.

作者信息

Ghobakhloo Nafiseh, Motazedian Mohammad Hossein, Fardaei Majid

机构信息

Dept. of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Basic Sciences in Infectious Diseases, Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Iran J Parasitol. 2016 Apr-Jun;11(2):168-176.

PMID:28096850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5236093/
Abstract

BACKGROUND

Treatment of Cutaneous Leishmaniasis (CL) is being faced with serious difficulties in Fars Province, due to emerging of resistance against meglumine antimonite (Glucantime®). In this context, determining some biomarkers for drug sensitivity monitoring seems to be highly essential. Different studies have been carried out to decipher the genes might be involved in antimony resistant phenotype in spp. Here, we selected three genes: AQP (as drug transporter), TDR-1-1(as drug activator), and γ-GCS (inducing reduction environment) for comparative expression analysis on clinical resistant and sensitive isolates of .

METHODS

The clinical isolates of were collected from CL patients referred to Valfajr Health Center, Shiraz from Oct 2011 to Feb 2012. The susceptibility test was performed to confirm drug sensitivity of strains in vitro as well. Then, the gene expression analysis was performed by quantitative real-time PCR using SYBR® Green.

RESULTS

By comparison of expression level between strains, up regulation of γ-GCS gene and down regulation of AQP gene were observed in resistant strains compared to the sensitive isolates; however, down regulation of AQP was not statistically specific. Analysis of TDR-1-1 gene unexpectedly showed a high level of expression in the non-responsive cases.

CONCLUSION

The γ-GCS, at least, can be considered as a suitable molecular marker for screening antimony sensitivity in clinical isolates, although AQP and TDR-1-1gene seem not to be reliable resistant markers.

摘要

背景

由于对葡甲胺锑酸盐(葡糖胺锑钠®)出现耐药性,法尔斯省皮肤利什曼病(CL)的治疗面临严重困难。在此背景下,确定一些用于药物敏感性监测的生物标志物显得至关重要。已经开展了不同的研究来破译可能参与利什曼原虫锑耐药表型的基因。在这里,我们选择了三个基因:水通道蛋白(AQP,作为药物转运体)、TDR-1-1(作为药物激活剂)和γ-谷氨酰半胱氨酸合成酶(γ-GCS,诱导还原环境),用于对利什曼原虫临床耐药和敏感分离株进行比较表达分析。

方法

2011年10月至2012年2月期间,从设拉子瓦尔法吉尔健康中心转诊的CL患者中收集利什曼原虫临床分离株。还进行了药敏试验以确认菌株在体外的药物敏感性。然后,使用SYBR® Green通过定量实时PCR进行基因表达分析。

结果

通过比较菌株之间的表达水平,与敏感分离株相比,耐药菌株中观察到γ-GCS基因上调和AQP基因下调;然而,AQP的下调在统计学上并不具有特异性。TDR-1-1基因分析意外地显示在无反应病例中表达水平较高。

结论

至少γ-GCS可被视为临床分离株中筛选锑敏感性的合适分子标志物,尽管AQP和TDR-1-1基因似乎不是可靠的耐药标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/994823629d09/IJPA-11-168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/b9260224e074/IJPA-11-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/3d6db29028fe/IJPA-11-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/994823629d09/IJPA-11-168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/b9260224e074/IJPA-11-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/3d6db29028fe/IJPA-11-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff4/5236093/994823629d09/IJPA-11-168-g003.jpg

相似文献

1
Expression Analysis of Multiple Genes May Involve in Antimony Resistance among Clinical Isolates from Fars Province, Central Iran.伊朗中部法尔斯省临床分离株中多个基因的表达分析可能与抗锑性有关。
Iran J Parasitol. 2016 Apr-Jun;11(2):168-176.
2
Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.运用实时逆转录聚合酶链反应对锑敏感及耐药的热带利什曼原虫临床分离株中活化蛋白激酶C基因(LACK1)进行表达分析。
Int J Dermatol. 2016 Sep;55(9):1020-6. doi: 10.1111/ijd.13321. Epub 2016 Jun 23.
3
Gene expression analysis of antimony resistance in Leishmania tropica using quantitative real-time PCR focused on genes involved in trypanothione metabolism and drug transport.定量实时 PCR 分析利什曼原虫抗锑基因表达,重点关注涉及三肽硫醇代谢和药物转运的基因。
Arch Dermatol Res. 2019 Jan;311(1):9-17. doi: 10.1007/s00403-018-1872-2. Epub 2018 Nov 2.
4
Evaluation of Correlation between the In Vitro Susceptibility of Field Isolates of and Clinical Outcomes of Meglumine Antimoniate Therapy in Fars Province, Iran.伊朗法尔斯省戊胺脒治疗的临床结果与现场分离株体外药敏性之间的相关性评估。
J Arthropod Borne Dis. 2017 Mar 14;11(1):132-138. eCollection 2017 Mar.
5
Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.无反应性 meglumine antimoniate 在人间皮肤利什曼病野外分离株:通过基因表达谱分析耐药生物标志物。
Trop Med Int Health. 2018 Jun;23(6):622-633. doi: 10.1111/tmi.13062. Epub 2018 May 21.
6
Phylogenetic analysis and antimony resistance of Leishmania major isolated from humans and rodents.从人和啮齿动物中分离的利什曼原虫的系统发育分析和抗锑性。
Acta Microbiol Immunol Hung. 2024 Mar 21;71(1):89-98. doi: 10.1556/030.2024.02194. Print 2024 Mar 26.
7
[Determination of Antimony Resistance Mechanism of Leishmania tropica Causing Cutaneous Leishmaniasis in Turkey].[土耳其引起皮肤利什曼病的热带利什曼原虫抗锑机制的测定]
Mikrobiyol Bul. 2020 Jul;54(3):444-462. doi: 10.5578/mb.69702.
8
gene expression in antimony resistance and susceptible isolates.抗锑和敏感菌株中的基因表达。
J Vector Borne Dis. 2016 Oct-Dec;53(4):370-374.
9
Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.泛美利什曼原虫(维氏亚属)和受感染巨噬细胞中锑反应基因的基因表达谱分析及其与药物敏感性的关系。
Acta Trop. 2017 Dec;176:355-363. doi: 10.1016/j.actatropica.2017.08.017. Epub 2017 Aug 24.
10
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.评估来自印度的对锑敏感和耐药的利什曼原虫临床分离株中的水甘油通道蛋白基因状态和表达谱。
J Antimicrob Chemother. 2010 Mar;65(3):496-507. doi: 10.1093/jac/dkp468. Epub 2010 Jan 12.

引用本文的文献

1
Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review.利什曼原虫 spp. 与皮肤利什曼病五价锑耐药相关的遗传因素:系统评价。
Mem Inst Oswaldo Cruz. 2024 Sep 2;119:e230240. doi: 10.1590/0074-02760230240. eCollection 2024.
2
Antimony resistance and gene expression in : spotlight on molecular and proteomic aspects.抗锑性与 : 分子和蛋白质组学方面的基因表达研究焦点。
Parasitology. 2024 Jan;151(1):1-14. doi: 10.1017/S0031182023001129. Epub 2023 Nov 28.
3
Green Approach: ''A Forwarding Step for Curing Leishmaniasis-A Neglected Tropical Disease''.

本文引用的文献

1
Drug repurposing and human parasitic protozoan diseases.药物再利用与人体寄生原生动物病。
Int J Parasitol Drugs Drug Resist. 2014 Mar 24;4(2):95-111. doi: 10.1016/j.ijpddr.2014.02.002. eCollection 2014 Aug.
2
Strategies to overcome antileishmanial drugs unresponsiveness.克服抗利什曼原虫药物无反应性的策略。
J Trop Med. 2014;2014:646932. doi: 10.1155/2014/646932. Epub 2014 Apr 30.
3
Antimony resistance and environment: Elusive links to explore during Leishmania life cycle.抗锑性与环境:在利什曼原虫生活史中探索难以捉摸的联系。
绿色方法:“治疗利什曼病(一种被忽视的热带疾病)的前进步骤”
Front Mol Biosci. 2021 May 28;8:655584. doi: 10.3389/fmolb.2021.655584. eCollection 2021.
4
Treatment Failure in Cutaneous Leishmaniasis Patients Referred to the School of Public Health, Tehran University of Medical Sciences during 2008-2017.2008年至2017年转诊至德黑兰医科大学公共卫生学院的皮肤利什曼病患者的治疗失败情况。
J Arthropod Borne Dis. 2020 Dec 31;14(4):363-375. doi: 10.18502/jad.v14i4.5274. eCollection 2020 Dec.
5
The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.PTR1 基因在感染热带利什曼原虫导致的非愈合性人类皮肤利什曼病中的潜在治疗作用。
J Clin Lab Anal. 2021 Mar;35(3):e23670. doi: 10.1002/jcla.23670. Epub 2020 Dec 7.
Int J Parasitol Drugs Drug Resist. 2012 Sep 3;2:200-3. doi: 10.1016/j.ijpddr.2012.07.003. eCollection 2012 Dec.
4
Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.通过 cDNA-AFLP 方法鉴定热带利什曼原虫田间分离株中的抗锑标记。
Exp Parasitol. 2013 Oct;135(2):344-9. doi: 10.1016/j.exppara.2013.07.018. Epub 2013 Aug 6.
5
Old World cutaneous leishmaniasis: diagnosis and treatment.旧大陆皮肤利什曼病:诊断与治疗
J Dermatol Case Rep. 2013 Jun 30;7(2):31-41. doi: 10.3315/jdcr.2013.1135.
6
Geographical distribution of leishmania species of human cutaneous leishmaniasis in fars province, southern iran.伊朗南部法尔斯省人类皮肤利什曼病利什曼原虫种类的地理分布
Iran J Parasitol. 2013 Jan;8(1):85-91.
7
Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.葡萄糖酸锑钠治疗伊朗中部皮肤利什曼病的疗效。
J Infect Public Health. 2013 Apr;6(2):120-4. doi: 10.1016/j.jiph.2012.11.003. Epub 2013 Feb 1.
8
Infectious diseases in Iran: a bird's eye view.伊朗的传染病:鸟瞰
Clin Microbiol Infect. 2012 Nov;18(11):1081-8. doi: 10.1111/1469-0691.12021. Epub 2012 Oct 3.
9
Leishmaniasis worldwide and global estimates of its incidence.全球利什曼病及其发病率的全球估计。
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
10
Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.天然利什曼原虫群体中药物耐药的分子机制随遗传背景而异。
PLoS Negl Trop Dis. 2012;6(2):e1514. doi: 10.1371/journal.pntd.0001514. Epub 2012 Feb 28.